Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04190134 · ClinicalTrials.gov registry record · Phase 1

Socially Assistive Robots to Enhance Magnification Device Use for Reading

A Phase 1 study of Low Vision, sponsored by University of California, Los Angeles.

Recruiting
Registry status
Phase 1
Development phase
20
Enrollment target
1
Study location

NCT04190134: Recruiting Phase 1 study of Low Vision, sponsored by University of California, Los Angeles.

NCT04190134 is a Phase 1 study of Low Vision that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 20 participants, below the 419-participant average among 8 other Low Vision trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04190134, a Phase 1 study of Low Vision, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
Phase 1
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The aims of this exploratory research project are to customize, deploy and evaluate the preliminary efficacy of a socially assistive robot as a novel approach to motivate and encourage optimal, long-term use of new magnification devices for reading in individuals with vision loss. The goals are to promote patient acceptance, adherence and skills reinforcement to achieve proficiency in the use of the magnifier, in order to attempt to reduce visual disability while performing important daily activities, such as reading tasks. This is a high priority given the increasing prevalence of low vision, paucity of low vision rehabilitation providers, and barriers related to access to care, such as transportation and geography, all of which motivate the development of this complementary approach for the provision of additional support at home by the socially assistive robot.

Conditions Studied

Interventions

  • BEHAVIORAL Socially Assistive Robot for Low Vision Rehabilitation

Study Locations (1)

California

  • UCLA Stein Eye Institute - Los Angeles

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2022-04-22
Est. Completion 2025-02
Phase Phase 1

What NCT04190134 shows while recruiting

NCT04190134 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 419-participant average among 8 other Low Vision trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Low Vision appearing as the primary indexed condition, and to 1 intervention - of which Socially Assistive Robot for Low Vision Rehabilitation is the first listed.

NCT04190134 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04190134 about?

NCT04190134 is a clinical study titled "Socially Assistive Robots to Enhance Magnification Device Use for Reading". The aims of this exploratory research project are to customize, deploy and evaluate the preliminary efficacy of a socially assistive robot as a novel approach to motivate and encourage optimal, long-term use of new magnification devices for reading in individuals with vision loss. The goals are to p...

What is the current status of trial NCT04190134?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2022-04-22. Estimated completion is 2025-02.

What conditions does trial NCT04190134 study?

This clinical trial studies the following conditions: Low Vision.

What interventions are being tested in trial NCT04190134?

The interventions under investigation include: Socially Assistive Robot for Low Vision Rehabilitation (BEHAVIORAL).

Who is sponsoring clinical trial NCT04190134?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04190134 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Low Vision

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04190134's enrollment target sits among peer trials

20 8th of 8 higher than 1 of 8 other Low Vision trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Low Vision trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04190134, the US trial registry maintained by the National Library of Medicine. NCT04190134 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.